It is not surprising that living through a pandemic has caused a rise in anxiety, particularly when it comes to our health.
Health anxiety is a recognised condition, characterised by obsessive thoughts about becoming or being ill.
According to the NHS, other symptoms include frequently checking body for signs of illness, always asking people for reassurance that you’re not ill, worries that medical tests may have missed something and obsessively looking at health information on the internet or in the media.
And with a near-constant media focus on coronavirus – its symptoms and its death rates – over the past 12 months, more and more people are suffering.
A Dutch study shortly after the pandemic hit confirmed that people who already had depressive, anxiety, or obsessive-compulsive disorders were experiencing a detrimental impact on their mental health from the Covid-19 pandemic.
For some people, the anxiety deteriorated to such an extent that could barely leave the house for fear of contracting the virus, with others leaving their jobs or spending hours washing everything that came into the house.
How to manage symptoms
However, there are ways to manage health anxiety and lessen its impact on daily life.
In recent months particularly, sufferers have been advised to limit the time they spent scouring the media for the latest news, and to stick to only reading credible sources.
Other advice included staying in touch with people (virtually, if necessary) and talking about any fears and worries, as well as eating a healthy diet and taking regular exercise.
The NHS also recommends keeping a diary of episodes of health anxiety, as well as techniques on how to challenge such intrusive thoughts.
If self-help techniques do not work, cognitive behavioural therapy is also recommended, which focuses on challenging intrusive thoughts and beliefs, and gradually changing behaviour.
While some restrictions are still in place, and people are beginning to find what they are comfortable doing, many of the activities that are often used to ease stress and anxiety are out of bounds.
And with concern mounting about a rise in alcohol use over the course of the pandemic, they are increasingly looking for alternative ways to ease their anxiety.
Enter CBD, which is well-known to help ease symptoms of anxiety, no matter what is causing them.
A recent poll found that more than a third (33 per cent) of Britons have tried CBD products, while 42 per cent have increased their usage since the outbreak of Covid-19, with anxiety the most common reason for using them.
In fact, it’s becoming such a popular remedy that a Canadian firm is currently developing a prescription drug based on the compound.
EmpowerPharm Inc is currently developing a unique prescription drug containing synthetic CBD as the active pharmaceutical ingredient to treat anxiety.
Earlier this year, Florida-based Nutrition Formulators published findings from a two-year study in the peer-reviewed Innovare Journal of Medical Science.
Examining worldwide clinical papers from 2019 and 2020, researchers found that more than 70 percent of CBD research on anxiety and stress showed positive outcomes.
The meta-analysis focused on CBD isolate and grouped the research into several categories, including CBD impacts on depression, sleep, panic attacks, dementia, inflammation, metabolism, behaviour, Parkinson’s disease, and psychiatric illnesses.
When looking at anxiety, the studies show that CBD reduces anticipator anxiety, such as speaking in public by affecting the part of the brain that processes emotional information.
Dr Marcelo Ferro, lead author and biochemist with Nutrition Formulators, said: “After spending 10 months reviewing the research, I was surprised at how many people with anxiety and depression could be helped by incorporating CBD into their lives.”
While more research is needed – there are worries that CBD could be no more than a sticking paster for anxiety – the short-term benefits could be perfectly suited to easing the symptoms of Covid-induced health anxiety.
Could cannabis help nurses experiencing physical pain while working?
Could the endocannabinoid system and CBD help with treating SAD?
A new study examines the role that the endocannabinoid system may play in regulating our moods such as stress, happiness and anxiety
A paper in the Brazilian Journal of Psychiatry has examined the potential of the endocannabinoid system to play a part in treating SADs.
Social anxiety disorder (SAD) is a common psychiatric disorder. People with SAD have an excessive fear or anxiety of social situations where they worry their behaviour may cause embarrassment, humiliation or rejection by others. This could be related to performance situations such as public speaking but may also be starting a conversation or socialising at an event. This may cause people to avoid attending events, work or relationships.
The NHS currently lists cognitive behavioural therapy (CBT) or anti-depressant medication as options for treatment with SAD.
The researchers reviewed existing scans of the brain to see if hormone imbalances could be the reason for the development of SAD. They examined dopamine which is responsible for how we feel pleasure, serotonin which stabilises our moods and the stress hormone cortisol.
They wrote: “The monoamine hypothesis and pharmacological approaches suggest that the neurobiologies of depression and anxiety share imbalances in the monoaminergic neurotransmission system.41 In this regard, neuro-molecular positron emission tomography (PET) and single-photon emission computed tomography (SPECT) studies in SAD have largely focused on imaging serotonergic and dopaminergic neurotransmission, based on the reported efficacy of antidepressants.”
The authors wrote: “Emerging evidence suggests that the endogenous cannabinoid system, also referred to as the endocannabinoid system (ECS), could play a potential role in the pathophysiology of SAD. This review discusses the known pathophysiological mechanisms of SAD, the potential role of the ECS in this disorder, current drugs targeting the ECS, and the potential of these novel compounds to enhance the therapeutic armamentarium for SAD.”
The researchers concluded that the ECS could be a potential biological pathway in the treatment of SAD and is a promising avenue for developing more therapeutic approaches. They highlighted that there is a lack of human ECS studies or clinical trials which allow for ‘significant gaps in our knowledge.’
Could CBD help?
The ECS involves three core components: endocannabinoids, receptors and enzymes. These receptors can be found throughout the body. Endocannabinoids bind to them to send a signal that the ECS needs to do something.
The main receptors are CB1 found in the central nervous system and CB2 in the peripheral nervous system. Endocannabinoids can bind to either receptor and produce effects depending on where the receptor is located and which one it binds to.
Tetrahydrocannabinol (THC) binds to CB1 or CB2 receptors while it is thought that potentially CBD can influence the receptors. Researchers aren’t sure how it interacts exactly.
A study explored the potential effects of CBD on people with SAD. Participants were given 400 mg of CBD or a placebo. Those given the CBD reported less anxiety than those given the placebo.
Another study on anxiety and sleep also revealed the potential of CBD to help stabilise our moods. The study involved 72 patients with 47 primarily experiencing anxiety and 25 suffering from poor quality sleep. Each person was given 25 milligrams of CBD each day and the majority of participants at 79.2 percent recorded they had lower anxiety while 66.7 percent reported better sleep after just the first month.
However, there is more research needed on both the endocannabinoid system and how CBD interacts with it to help treat SAD.
One in five autism caregivers give their child CBD products
A new report by reveals that the majority of parents started using oils during the pandemic for older children.
A study by Autism Parenting Magazine revealed that almost 20 percent of people caring for an autistic child give them CBD products.
The autism parenting survey was sent to 160,000 subscribers around the world revealing the extent of CBD use by parents caring for an autistic child. 18.6 percent of respondents confirmed they use CBD for a child on the spectrum to relieve a variety of their symptoms. This was further broken down to 22.16 percent of US parents compared to 14.29 percent of UK families.
It is estimated that there are 700,000 people in the UK with a diagnosis of autism. This is equal to one in 100 children in the UK.
The new survey also revealed that 31.3 percent of those using CBD products started during the Covid-19 pandemic. A further 16.6 percent revealed they have increased the amount since the pandemic began. The reason for this was thought to be down to increased anxiety and panic.
The data showed 76.3 percent CBD only use while the remaining 10 percent used other forms such as hemp, CD/THC and Epidiolex or CBD with terpenes.
The majority of those who responded were parents at 72.4 percent but there were also grandparents, careers, teachers, therapists, doctors or individuals on the spectrum.
Autism symptom relief
The survey revealed that the primary use for CBD was anxiety relief at 42.9 percent or challenging behaviour at 36.9 percent. The rest stated pain relief, inflammation, sleep or relaxation. A small number of parents, 4.3 percent, said seizures. Other reasons were given as speech or supporting potty training.
The survey also asked how much support the parents felt their child needed with 42.9 percent stating ‘requires substantial support.’ A small number at 17.9 percent said very substantial support. CBD use tended to be daily in the form of oils.
Oils were a favourite amongst parents with 60.8 percent opting to use this method. Other popular methods included 21.5 percent using gummies, 7.5 percent consuming capsules or tablets. A few used lotions or balms while 1.9 percent used vapes.
A large number of participants used CBD for their teenagers with 21.39 percent confirming their child was aged 13 to 18.
Only a small number of parents were combining the CBD with therapies at 7.4 percent. The therapy was listed as Applied Behaviour Analysis Therapy (ABA Therapy). ABA therapy considers a person’s understanding of how behaviour works in real situations. The aim of therapy is to increase helpful and decrease unhelpful behaviours that could be harmful or affect learning. ABA is being used increasingly in the UK.
Introducing our new B2B title
- Is it time for a T (tolerance)-break?
- 95% of patients with rare skin condition report improvements with cannabis topicals
- How do I access a medical cannabis prescription?
- Patient Voices: “I feel like I can plan for the future instead of having to take one day at a time”
- How The Good Level is changing the UK CBD market for the better
- Cannabis legalisation not linked to rise in car accidents, says study
News10 months ago
Community extends support to cannabis icon Rick Simpson
News1 year ago
NHS lines up cannabis medicine manufacturing
Case Studies2 years ago
CBD oil and fibromyalgia – a case study
News12 months ago
Cancer survivor claims cannabis oil helped her beat brain tumour
Insight11 months ago
I’ve gone from a wheelchair to walking thanks to cannabis
News9 months ago
UK grants second licence to grow high-THC medical cannabis
Feature1 year ago
Medical cannabis could help long-term effects of COVID-19, says David Nutt
Industry8 months ago
“Game changer” for the sector: First cannabis company expected to list on LSE next month